REV1 and neoplasm: There is an interaction between ineffective DNA damage repair and metabolic imbalance, which in turn is an important factor affecting tumor radiosensitivity; therefore, REV1 is expected to be a therapeutic target for enhancing tumor radiosensitivity [30].